Skip to main content
Caplight Logo









Risklick AG

Risklick AG

Private
BernHealthcare & Life Scienceshttps://risklick.ch/

Last Round

Seed

Apr 23, 2024

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Risklick AG is a health technology company that develops AI-powered software for clinical trial protocol development and optimization.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Compliance & Risk, Vertical SaaS, Biotechnology

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical trial designclinical trial softwareprotocol designclinical trial riskeClinicalclinical trial automationAI clinical trialscontract research organizationCROclinical study protocoltrial feasibilityclinical trial planningvertical SaaSregulatory complianceclinical trial tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Risklick AG Comparables

Compare Risklick AG with similar companies based on industry and business-model similarity.

Risklick AG comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AIRA Health
89%
Espero Health
86%
B1 Health Corp
85%

Risklick AG Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 23, 2024
GrantOct 27, 2023
AcceleratorSep 12, 2023

Key People

Founding team and executive leadership

Poorya Amini

Chief Executive Officer (CEO) at Risklick AG

Executive Team

Philipp Khlebnikov

CTO, Senior Data Scientist

Executive Team

Risklick AG Investors

Notable investors and investment history

Risklick AG investors
InvestorRounds
DayOneAccelerator
InnosuisseGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 3, 2026

    Open roles increased from 0 to 12, representing 80% of headcount.

  • Jan 20, 2026

    Grew 23% QoQ, from 13 to 16 employees.

Risklick AG Filings

Explore SEC and related filing metadata, where available.

Risklick AG filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Risklick AG's valuation, stock price, and market status.

Is Risklick AG a public or private company?

Risklick AG is a private company.

What is the current stock price of Risklick AG?

Risklick AG is a private company with no public stock price. No recent secondary market data is available.

How much is Risklick AG worth (valuation)?

Valuation information for Risklick AG is not publicly available.

Can I buy Risklick AG stock?

Risklick AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Risklick AG's last funding round?

Risklick AG's most recent funding round was Seed on April 23, 2024.

Who are the main investors in Risklick AG?

Key investors in Risklick AG include DayOne, Innosuisse.

Will Risklick AG IPO soon?

No public IPO plans have been announced for Risklick AG.

How can I track Risklick AG secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Risklick AG's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBern
Employee Range15
Year Founded2019
Last FundingApr 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?